The International Symposium of Gastrointestinal Oncology (ISGIO 2024) is dedicated to the latest advances in gastrointestinal (GI) cancer research, and critical issues in the care of people with GI cancer.
The International Symposium of Gastrointestinal Oncology (ISGIO 2024) covers topics such as:
- Clinical trial readouts in the context of how testing for actionable genomic alterations should be implemented among patients with cancer
- Evidence supporting the use of biomarkers for risk stratification and prognostic assessment across cancer types
- Multidisciplinary decision-making in the assessment and application of genomic testing results along the cancer care continuum
- How specific genomic alterations and biomarkers can be leveraged to inform risk stratification and treatment planning in cancer
The International Symposium of Gastrointestinal Oncology (ISGIO 2024) brings together health professionals with an interest in GI oncology including:
- Oncologists and practitioners of oncology subspecialties
- Surgeons
- General scientists
- Radiologists
- Nurses
- Young investigators
- Pharmacists
The International Symposium of Gastrointestinal Oncology (ISGIO 2024) will be held in Hollywood, United States on 11-12 Oct 2024.
